PT - JOURNAL ARTICLE AU - Maldonado-Diaz Ellis Daniela AU - Soto-Hernández José Luis AU - Salinas-Lara Citlaltepetl AU - Kammar-Garcia Ashuin AU - Cárdenas Graciela TI - Tuberculous meningitis in adult patients of a Mexican neurological referral center: A-six-year retrospective cohort study AID - 10.1101/2020.12.02.20242420 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.02.20242420 4099 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242420.short 4100 - http://medrxiv.org/content/early/2020/12/04/2020.12.02.20242420.full AB - Introduction Tuberculosis (TB) remains as an important concern of public health worldwide because the high prevalence and severe sequelae. Tuberculous meningitis (TBM) is the most lethal and disabling form.Aim To describe the clinical, laboratory, and neuroimaging characteristics of TBM on admission at neurological center in Mexico City.Methods Retrospective cohort study at the third level neurological center from 2010 to 2016. Clinical follow-up was evaluated at hospital discharge, three months, and one-year either due to lack of follow-up or mortality, during the follow-up the adverse events were registered.Results One-hundred and six patients were included, 74 (69.8%) males and 32 (30.2%) females. From these 31 (29.2%) were HIV-positive. The median age was 35.5 (IQR:28-51). Pulmonary TB was found in 25% of the population. Alcoholism was observed in a half of the patients while diabetes in 15%, the latter being significant (p=0.04). Abnormalities in neuroimaging were significant among our population (p=0.003). Only one-third of the population had a positive Lowenstein-Jensen culture. There were no differences in clinical outcomes between HIV positive and non-HIV patients.Conclusion Our study shows data to those described in the literature. The initiation of empirical treatment in all patients with a high clinical suspicion of tuberculosis mandatory to try to avoid severe neurological sequels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was approved (protocol 85/17) by the research and ethics committees of the Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data are available upon request from the authors